These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6231704)

  • 1. The effect of streptozotocin and streptozotocin-induced diabetes on the kidney.
    Evan AP; Mong SA; Gattone VH; Connors BA; Aronoff GR; Luft FC
    Ren Physiol; 1984; 7(2):78-89. PubMed ID: 6231704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of alloxan, and alloxan-induced diabetes on the kidney.
    Evan AP; Mong SA; Connors BA; Aronoff GR; Luft FC
    Anat Rec; 1984 Jan; 208(1):33-47. PubMed ID: 6711836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strict metabolic control and renal function in the streptozotocin diabetic rat.
    Jensen PK; Christiansen JS; Steven K; Parving HH
    Kidney Int; 1987 Jan; 31(1):47-51. PubMed ID: 3550216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The morphology of diabetic nephropathy in experimental diabetes induced by low doses of streptozotocin].
    Varshavskiĭ VA; Ponomarev AB; Bazarova AV; Karelin AA; Pankov IuA; Kondrat'ev IaIu; Keda IuM; Gorskova VA
    Arkh Patol; 1990; 52(7):43-8. PubMed ID: 2149496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats.
    Deepa B; Venkatraman Anuradha C
    Toxicol Mech Methods; 2013 May; 23(4):223-34. PubMed ID: 23193997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of pentoxifylline on diabetic renal changes in streptozotocin-induced diabetes mellitus.
    Gunduz Z; Canoz O; Per H; Dusunsel R; Poyrazoglu MH; Tez C; Saraymen R
    Ren Fail; 2004 Nov; 26(6):597-605. PubMed ID: 15600249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal prostanoids in experimental diabetes mellitus].
    Kucherenko AG; Zadkova GF; Markov KhM; Poleshchuk VS
    Vopr Med Khim; 1994; 40(6):37-9. PubMed ID: 7618299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal microvascular changes in streptozotocin-induced, long-termed diabetic rat.
    Sricharoenvej S; Tongpob Y; Lanlua P; Piyawinijwong S; Roongruangchai J; Phoungpetchara I
    J Med Assoc Thai; 2007 Dec; 90(12):2677-82. PubMed ID: 18386720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of compensatory hypertrophy of the kidney].
    Klin M
    Postepy Hig Med Dosw; 1990; 44(1-3):85-112. PubMed ID: 2151468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long acting insulin supplementation on diabetic nephropathy in Wistar rats.
    Michael ST; Ganesh RN; Viswanathan P
    Indian J Exp Biol; 2012 Dec; 50(12):867-74. PubMed ID: 23986970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin preserves renal function in experimental diabetes.
    Inman SR; Stowe NT; Cressman MD; Brouhard BH; Nally JV; Satoh S; Satodate R; Vidt DG
    Am J Med Sci; 1999 Apr; 317(4):215-21. PubMed ID: 10210355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
    Raz I; Rubinger D; Popovtzer M; Grønbaek H; Weiss O; Flyvbjerg A
    Diabetes; 1998 Jun; 47(6):924-30. PubMed ID: 9604870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy.
    Sanai T; Sobka T; Johnson T; el-Essawy M; Muchaneta-Kubara EC; Ben Gharbia O; el Oldroyd S; Nahas AM
    Diabetologia; 2000 Jan; 43(1):91-100. PubMed ID: 10663221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations.
    Luippold G; Bedenik J; Voigt A; Grempler R
    PLoS One; 2016; 11(6):e0156346. PubMed ID: 27253523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats.
    Flyvbjerg A; Frystyk J; Thorlacius-Ussing O; Orskov H
    Diabetologia; 1989 Apr; 32(4):261-5. PubMed ID: 2759363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
    Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of renal tumorigenicity by cyclosporine A in streptozotocin diabetic rats.
    Reddi AS; Jyothirmayi GN; Halka K; Khan MY
    Cancer Lett; 1991 Feb; 56(2):109-15. PubMed ID: 1825617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
    Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ
    J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats.
    Anbar HS; Shehatou GS; Suddek GM; Gameil NM
    Eur J Pharmacol; 2016 Jun; 780():82-92. PubMed ID: 27012991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of calcium and insulin on hyperfiltration of early diabetes.
    Bank N; Lahorra MA; Aynedjian HS
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E13-20. PubMed ID: 3101508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.